Unknown

Dataset Information

0

The Quality of Anti-SARS-CoV-2 T Cell Responses Predicts the Neutralizing Antibody Titer in Convalescent Plasma Donors.


ABSTRACT: Convalescent plasma therapy has been described as an attractive approach to treat critically ill patients with COVID-19 (Coronavirus disease 2019). The selection of convalescent plasma donors (CPD) is commonly based on neutralizing antibody titer. A better understanding of the quality of immune responses following COVID-19 will enable the optimization of convalescent donors' selection in convalescent plasma programs. The involvement of SARS-CoV-2 specific T cells in the induction and persistence of high affinity anti-SARS-CoV-2 neutralizing antibody is still poorly investigated. In this study, 115 CPD who presented SARS-CoV-2 and who were eligible for plasma donation were included. Comprehensive analysis of T cells together with humoral responses were performed in regards of sex, age and blood group type. High frequency of T cell responses against SARS-CoV-2 related protein such as spike glycoprotein (80.0%), nucleocapsid (NCAP) (70.4%) and membrane protein (VME1) (74.8%) were detected in CPD by ex vivo IFN-γ and TNF-α ELISpot assays. Among CPD responders, most exhibited poly-specific T cell responses (75%) defined by the ability to mount responses against at least two SARS-CoV-2 antigens. We found a positive correlation between the magnitude and the poly-specificity of anti-SARS-CoV-2 T cell responses in CPD. Notably, both the magnitude and poly-specificity of SARS-CoV-2 T cell responses were highly correlated with neutralizing antibody titer in CPD. The present study highlights that the poly-specificity and strength of SARS-CoV-2 specific T cell responses predicts neutralizing antibody titer following COVID-19. These observations show the interest to combine T cell assays and antibody titer for the selection of CPD and to a latter extend to assess COVID-19 vaccine efficacy in at-risk patients.

SUBMITTER: Kroemer M 

PROVIDER: S-EPMC8965758 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature

altmetric image

Publications

The Quality of Anti-SARS-CoV-2 T Cell Responses Predicts the Neutralizing Antibody Titer in Convalescent Plasma Donors.

Kroemer Marie M   Boullerot Laura L   Ramseyer Mélanie M   Spehner Laurie L   Barisien Christophe C   Gravelin Eleonore E   Renaudin Adeline A   Cognasse Fabrice F   Gallian Pierre P   Hermine Olivier O   Lacombe Karine K   Tiberghien Pierre P   Adotévi Olivier O  

Frontiers in public health 20220316


Convalescent plasma therapy has been described as an attractive approach to treat critically ill patients with COVID-19 (Coronavirus disease 2019). The selection of convalescent plasma donors (CPD) is commonly based on neutralizing antibody titer. A better understanding of the quality of immune responses following COVID-19 will enable the optimization of convalescent donors' selection in convalescent plasma programs. The involvement of SARS-CoV-2 specific T cells in the induction and persistence  ...[more]

Similar Datasets

| S-EPMC7499592 | biostudies-literature
| S-EPMC7665673 | biostudies-literature
| S-EPMC7710271 | biostudies-literature
| S-EPMC7760522 | biostudies-literature
| S-EPMC9348319 | biostudies-literature
| S-EPMC10420400 | biostudies-literature
| S-EPMC9675084 | biostudies-literature
| S-EPMC8419417 | biostudies-literature
| S-EPMC9617541 | biostudies-literature
| S-EPMC7732494 | biostudies-literature